STING AGONISTIC COMPOUND

The present invention addresses the problem of providing a pharmaceutical product containing, as an active ingredient, a compound having agonistic activity to STING. As a result of extensive investigations, the inventors of the present invention have discovered, as substances capable of solving the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HANADA, Ryosuke, KURONO, Masakuni, HAGIYA, Hiroshi, KOUDA, Kenichi, KOKUBO, Masaya
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention addresses the problem of providing a pharmaceutical product containing, as an active ingredient, a compound having agonistic activity to STING. As a result of extensive investigations, the inventors of the present invention have discovered, as substances capable of solving the problem, compounds represented by general formula (I-1) [all of the symbols in the formula are as described in the description] and having agonistic activity to STING, thereby arriving at the present invention. The compounds represented by general formula (I-1) according to the present invention have agonistic activity to STING, and can thus be used as active ingredients of agents for treating, suppressing the progress of, and/or suppressing the recurrence of cancer or infectious diseases.